Following the deaths of 15 infants, families are advised to immediately stop using all models of Kids2 Rocking Sleepers, according to a second recall notice. Four of those 15 babies died after the first recall notice, the U.S. Consumer Product Safety Commission (CPSC) reported. The company is recalling 694,000 Rocking Sleepers. Parents can contact the…  read on >  read on >

U.S. stroke deaths have dramatically declined in the past several decades. But, researchers caution, their new study also found the potential for a resurgence. “After nearly four decades of declining stroke-related mortality, the risk appears to be increasing in the United States. Our research underscores the need for novel strategies to combat this alarming trend,”…  read on >  read on >

For the first time in a decade, the U.S. Environmental Protection Agency has proposed strengthening standards on fine soot in the air, a known contributor to serious health issues. Under the new proposal, standards for fine particulate pollution, known as PM 2.5, would change from a level of 12 micrograms per cubic meter to a…  read on >  read on >

A new way of allocating donor lungs that eliminates geographical restrictions could save more lives, new research suggests. In early 2023, the current U.S. system, which looks for compatible candidates within a fixed radius, will be replaced by the Composite Allocation Score. The new score will prioritize a candidate’s medical needs. “The importance of removing…  read on >  read on >

If you’re sick or have been injured, you might not know whether the emergency room or urgent care is the right place to be treated. The American College of Emergency Physicians (ACEP) offers some general advice, so you don’t have to wonder where to go when immediate medical attention is needed. “The emergency department is…  read on >  read on >

The U.S. Food and Drug Administration on Friday approved a second Alzheimer’s drug, lecanemab, despite reports of rare brain bleeds linked to use of the drug in some patients. However, the FDA pointed to the drug’s benefits, as well. “Alzheimer’s disease immeasurably incapacitates the lives of those who suffer from it and has devastating effects…  read on >  read on >